Haloperidol injection
Products billed under this code include Haloperidol Lactate.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Haloperidol Lactate.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Haloperidol Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9501-25 | 25 | $15.80 |
| Haloperidol Lactate | Hikma Pharmaceuticals USA Inc. | 00143-9502-01 | 10 | $6.32 |
| Haloperidol Lactate | Henry Schein Inc. | 00404-9871-01 | 1 | $0.632 |
| Haloperidol Lactate | Sagent Pharmaceuticals | 25021-0806-01 | 10 | $6.32 |
| Haloperidol Lactate | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1524-01 | 1 | $0.632 |
| Haloperidol Lactate | FreseniUS Kabi USA, LLC | 63323-0474-01 | 25 | $15.80 |
| Haloperidol Lactate | FreseniUS Kabi USA, LLC | 63323-0474-10 | 10 | $6.32 |
| Haloperidol Lactate | Mylan Institutional LLC | 67457-0426-12 | 25 | $15.80 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.632 | −$0.114 | 5 MG | Haloperidol injection | v1, posted September 17, 2026 |
| 3Q26 | $0.746 | −$0.043 | 5 MG | Haloperidol injection | v1, posted September 15, 2026 |
| 2Q26 | $0.789 | +$0.059 | 5 MG | Haloperidol injection | v1, posted September 15, 2026 |
| 1Q26 | $0.73 | −$0.072 | 5 MG | Haloperidol injection | v1, posted September 15, 2026 |
| 4Q25 | $0.802 | −$0.034 | 5 MG | Haloperidol injection | v1, posted September 8, 2026 |
| 3Q25 | $0.836 | +$0.06 | 5 MG | Haloperidol injection | v1, posted March 10, 2026 |
| 2Q25 | $0.776 | −$0.431 | 5 MG | Haloperidol injection | v1, posted March 10, 2026 |
| 1Q25 | $1.207 | +$0.177 | 5 MG | Haloperidol injection | v1, posted December 19, 2025 |
| 4Q24 | $1.03 | −$0.127 | 5 MG | Haloperidol injection | v1, posted June 11, 2025 |
| 3Q24 | $1.157 | −$0.105 | 5 MG | Haloperidol injection | v1, posted June 11, 2025 |
| 2Q24 | $1.262 | −$0.154 | 5 MG | Haloperidol injection | v1, posted March 11, 2025 |
| 1Q24 | $1.416 | +$0.175 | 5 MG | Haloperidol injection | v1, posted December 19, 2024 |
| 4Q23 | $1.241 | −$0.142 | 5 MG | Haloperidol injection | v1, posted October 10, 2024 |
| 3Q23 | $1.383 | +$0.229 | 5 MG | Haloperidol injection | v1, posted June 5, 2024 |
| 2Q23 | $1.154 | +$0.296 | 5 MG | Haloperidol injection | v1, posted February 23, 2024 |
| 1Q23 | $0.858 | −$0.757 | 5 MG | Haloperidol injection | v1, posted December 6, 2023 |
| 4Q22 | $1.615 | +$0.881 | 5 MG | Haloperidol injection | v1, posted June 22, 2023 |
| 3Q22 | $0.734 | −$0.514 | 5 MG | Haloperidol injection | v1, posted June 9, 2023 |
| 2Q22 | $1.248 | +$0.161 | 5 MG | Haloperidol injection | v1, posted December 14, 2022 |
| 1Q22 | $1.087 | −$0.368 | 5 MG | Haloperidol injection | v1, posted June 8, 2022 |
| 4Q21 | $1.455 | −$0.354 | 5 MG | Haloperidol injection | v1, posted June 2, 2022 |
| 3Q21 | $1.809 | +$0.377 | 5 MG | Haloperidol injection | v1, posted June 2, 2022 |
| 2Q21 | $1.432 | +$0.539 | 5 MG | Haloperidol injection | v1, posted March 1, 2022 |
| 1Q21 | $0.893 | – | 5 MG | Haloperidol injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.